SHUBHAM PANT to Cross-Over Studies
This is a "connection" page, showing publications SHUBHAM PANT has written about Cross-Over Studies.
Connection Strength
0.031
-
Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2016 Nov; 78(5):921-927.
Score: 0.031